IL1B and ischemic stroke: To evaluate whether SR9009 protects against the inflammatory and oxidative damage in the ischemic stroke, multiple inflammatory mediators including TNFα, IL-1β and iNOS (Figures 4A–C) in the ischemic cortex were detected at 24 h after MCAO.